BioSpace News Archive

Roche announced results from its Phase III PEMPHIX trial evaluated MabThera/Rituxan (rituximab) compared to mycophenolate mofetil (MMF) in adults with moderate to severe pemphigus vulgaris.

A new study shows that a PARP inhibitor combined with a DNA methyltransferase inhibitor may be a new way of treating some lung cancers.

The U.S. Food and Drug Administration approved Eli Lilly’s Reyvow (lasmiditan) for the acute treatment of migraines.

The drug met all the co-primary and key secondary endpoints related to skin clearance and itch relief compared to placebo.

The U.S. Food and Drug Administration approved Janssen Pharmaceutical’s Xarelto for the prevention of venous thromboembolism, or blood clots, in acutely sick patients in hospitals who are at risk for blood clots but who are not at high risk of bleeding.

Researchers found that an injectable hormone called tesamorelin decreases liver fat and prevented liver fibrosis in this patient population.

SubioMed, Inc. (“SubioMed™” or the “Company”), a pioneer in the invention and development of Suspension Biomechanics™ technology addressing critical elements of gait and balance, today announced that its Chief Executive Officer Patrick Kullmann will present at The Network Connect’s Investor Connection Meeting (“ICE”) in Minneapolis on October 22, 2019.

Admedus Limited (AHZ or the Company) announces the sale of its CardioCel® and VascuCel® patch business to U.S based LeMaitre Vascular Inc. (NASDAQ: LMAT, ‘LeMaitre’), for up to $A36.2M ($A22.8M upfront) in cash payments to Admedus.

SS&C Technologies Holdings, Inc. (Nasdaq: SSNC), a global provider of financial services and healthcare software and software-enabled services, will announce its financial results for the third quarter 2019 ended September 30, 2019 after the close of the market on Thursday, October 31, 2019.

ExxonMobil said that it has signed agreements with the Indian Institute of Technology locations in Madras and Bombay, further expanding its extensive portfolio of research collaboration with India’s universities.